Andrew Lew — ASN Events
  1. Schedule
  2. Andrew Lew

Andrew Lew

Walter & Eliza Hall Institute, VIC, Australia

  • This delegate is presenting an abstract at this event.
Veterinary surgeon from Melbourne University. PhD London on immune complexes and glomerulonephritis. Postdoc NIH on MHC, discovered gd TCR in the mouse. Currently, Lab Head, Immunology Division, Walter & Eliza Hall Institute, working on type 1 diabetes, with focus on local immunosuppression in islet allo- and xeno-transplantation and the role of dendritic cells in transplantation and vaccines.
Presentations this author is a contributor to:

Preclinical xenotransplantation of genetically altered porcine neonatal islet cell clusters that express human CD55 and CD59 and Gal KO prevent thrombosis are a step closer to cure type 1 diabetes. (#157)

6:00 PM
Wayne J Hawthorne
POSTER SESSION 2 / DRINKS

On the road to unraveling the mechanistic pathways of the Instant Blood Mediated Inflammatory Reaction against Porcine Neonatal Islet Cells. (#158)

6:00 PM
Wayne J Hawthorne
POSTER SESSION 2 / DRINKS

  Assessing insulin-specific T-cell tolerance in the NOD mouse model tolerant to proinsulin (#70)

5:05 PM
Jonathan Chee
POSTER SESSION 1 / DRINKS

  Effector-Memory T-Cells develop in islets and report islet pathology in Type 1 diabetes (#71)

5:05 PM
Jonathan Chee
POSTER SESSION 1 / DRINKS

  Rotavirus infection causes pancreatic apoptosis, ß-cell dysfunction and transient hyperglycemia (#86)

5:05 PM
Margo C Honeyman
POSTER SESSION 1 / DRINKS

Localized intervention in islet transplantation: at the coal face (#55)

4:40 PM
Andrew Lew
BETA CELL DEVELOPMENT AND REPLACEMENT